Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans

被引:17
作者
Forouhi, NG
Rumley, A
Lowe, GD
McKeigue, P
Sattar, N
机构
[1] Glasgow Royal Infirm, Dept Pathol Biochem, Glasgow G4 0SF, Lanark, Scotland
[2] Univ Glasgow, Glasgow Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland
[3] London Sch Hyg & Trop Med, Epidemiol Unit, London WC1, England
关键词
haemostatic factors; ethnicity; adiposity; metabolic syndrome; coronary heart disease;
D O I
10.1097/00001721-200312000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated levels of haemostatic factors including tissue plasminogen activator (t-PA) antigen are associated with coronary heart disease in Europeans but data in South Asians are sparse. We performed a cross-sectional study of 111 healthy men and women aged 40-55 years (56 European and 55 Asian) frequency matched across a wide range of body mass index (17 - 34 kg/m(2)). All subjects had detailed adiposity and metabolic measurements, and five haemostatic factors were determined. South Asians had greater insulin resistance than Europeans (fasting insulin geometric mean, 7.1 versus 4.7 muU/ml, and 2-h insulin, 37.3 versus 14.1 muU/ml, respectively). There were no significant ethnic differences in the mean concentrations of fibrinogen, factor VII, von Willebrand factor, or fibrin D-dimer (P > 0.10). However, the t-PA antigen concentration was significantly elevated in South Asians compared with Europeans (mean, 10.6 versus 8.2 ng/ml, P = 0.001). t-PA correlated positively in both ethnic groups with features of the metabolic syndrome but the ethnic difference in t-PA persisted after adjustment for adiposity, metabolic and inflammatory variables (beta = 2.0, 95% confidence interval = 0.5-3.6, P = 0.012). We therefore hypothesize that elevated t-PA antigen may be a novel mechanism contributing to increased cardiovascular risk in South Asians. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:755 / 760
页数:6
相关论文
共 36 条
[1]  
Agewall S, 2000, THROMB HAEMOSTASIS, V84, P571
[2]   Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) [J].
Anand, SS ;
Yusuf, S ;
Vuksan, V ;
Devanesen, S ;
Teo, KK ;
Montague, PA ;
Kelemen, L ;
Yi, CL ;
Lonn, E ;
Gerstein, H ;
Hegele, RA ;
McQueen, M .
LANCET, 2000, 356 (9226) :279-284
[3]   Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Kooner, JS .
HEART, 1999, 81 (05) :501-504
[4]   C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites [J].
Chambers, JC ;
Eda, S ;
Bassett, P ;
Karim, Y ;
Thompson, SG ;
Gallimore, JR ;
Pepys, MB ;
Kooner, JS .
CIRCULATION, 2001, 104 (02) :145-150
[5]   Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects -: The BIGPRO1 study [J].
Charles, MA ;
Morange, P ;
Eschwège, E ;
André, P ;
Vague, P ;
Juhan-Vague, I .
DIABETES CARE, 1998, 21 (11) :1967-1972
[6]   Computed tomography-determined body composition in relation to cardiovascular risk factors in Indian and matched Swedish males [J].
Chowdhury, B ;
Lantz, H ;
Sjostrom, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (05) :634-644
[7]  
Danesh J, 2001, CIRCULATION, V103, P2323
[8]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[9]   Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Schneider, DJ ;
Sobel, BE ;
Cavaghan, MK ;
Imperial, J ;
Rosenfield, RL ;
Polonsky, KS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2108-2116
[10]   Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study [J].
Festa, A ;
D'Agostino, R ;
Tracy, RP ;
Haffner, SM .
DIABETES, 2002, 51 (04) :1131-1137